Auscann Group Holdings Ltd

ASX:AC8 ISIN:AU000000AC89

AusCann Group Holdings (ASX:AC8)AusCann Group Holdings Limited (ASX: AC8) is an Australian-based pharmaceutical company focused on the development, production, and distribution of cannabinoid-based medicines within Australia and internationally.

AusCann transforms the way medicinal cannabis is dispensed today by making standardised, controlled dose products, providing educational support to healthcare professionals and generating clinical evidence that is accessible to patients, physicians and healthcare providers. AusCann is developing a pipeline of proprietary differentiated cannabinoid-based pharmaceutical products. The Company's first product was successfully launched in Australia in 2020 and is available under special access provisions for medicines.

 
   

News

AusCann Group Holdings Ltd (ASX:AC8) and CannPal Enter Into Scheme of Arrangement

🕔11/16/2020 12:10:39 PM 3294

AusCann Group Holdings Ltd (ASX:AC8), an Australian based pharmaceutical company focused on the development, production and distribution of cannabinoid-based medicines within Australia and internationally, is pleased to announce that it has entered into a scheme implementation deed (SID) with CannPal Animal Therapeutics Limited.

Read Full Article

Chapmans Limited (ASX:CHP) Investment Update - MJ Life Sciences

🕔9/25/2017 8:51:38 AM 8604

The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that the Company has successfully completed it's strategic investment in MJ Life Sciences Pty Ltd referred to in the Company's previous announcements of 23 and 29 August.

Read Full Article

Chapmans Limited (ASX:CHP) to Make Strategic Medicinal Cannabis Sector Investment

🕔8/29/2017 12:35:47 PM 8668

The Directors of Chapmans Limited (ASX:CHP) are pleased to announce that the Company has entered into a Binding Heads of Agreement with MJ Life Sciences Pty Ltd, to make a strategic investment of US$500,000 in MJLS.

Read Full Article

Chapmans Limited (ASX:CHP) Business Update

🕔8/23/2017 10:22:38 AM 7502

The Directors of Chapmans Limited (ASX:CHP) (Chapmans, the Company) are pleased to provide the following update on it's investments and activities.

Read Full Article
###

5,216 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 7) (Last 30 Days: 46) (Since Published: 5216) 

Company Data

    Principal Sector
  • Cannabis and Hemp 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.auscann.com.au

Social Media